Thursday 8 September 2011

Reduction mammaplasty, obesity and massive weight loss

Reduction mammaplasty, obesity and massive weight loss: Temporal relationships of satisfaction with breast contour. Plastic and reconstructive surgery, Sept 2011, vol. 128(3), p. 643-650.

Coriddi, M., et al.

http://journals.lww.com/plasreconsurg/Fulltext/2011/09000/Reduction_Mammaplasty,_Obesity,_and_Massive_Weight.3.aspx

Reduction mammaplasty is often performed on obese women. With the rise in bariatric procedures, secondary changes to breast contour are increasing. This study aims to investigate the temporal relationships of breast contour satisfaction with weight status.

Anaplastic large cell lymphoma and breast implants

Anaplastic large cell lymphoma and breast implants: Results from a structured expert consultation process. Plastic and reconstructive surgery, Sept 2011, vol. 128(3), p. 629-639.

Kim, B., et al.

http://journals.lww.com/plasreconsurg/Fulltext/2011/09000/Anaplastic_Large_Cell_Lymphoma_and_Breast.1.aspx

There are increasing concerns about a possible association between anaplastic large cell lymphoma (ALCL) and breast implants. The authors conducted a structured expert consultation process to evaluate the evidence for the association, its clinical significance, and a potential biological model based on their interpretation of the published evidence.

A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast

A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plastic and reconstructive surgery, Sept 2011, vol. 128(3), p. 112e-118e.

Carty, MJ, et al.

http://journals.lww.com/plasreconsurg/Fulltext/2011/09000/A_Patient_Death_Attributable_to_Implant_Related.5.aspx

Implant-related primary anaplastic large cell lymphoma (ALCL) of the breast is a rare clinical entity. With increasing attention being paid to this disease, most cases reported to date in the literature have demonstrated indolent clinical courses responsive to explantation, capsulectomy, chemotherapy, and/or radiotherapy. The authors describe a case of bilateral implant-related primary ALCL of the breast that proved refractory to both standard and aggressive interventions, ultimately resulting in patient death secondary to disease progression. The authors situate this case in the context of the current state of knowledge regarding implant-related primary ALCL of the breast and suggest that this entity is generally, but not universally, indolent in nature.

Anaplastic large T-cell lymphoma and breast implants

Anaplastic large T-cell lymphoma and breast implants: A review of the literature. Plastic and reconstructive surgery, Sept 2011, vol. 128(3), p. 651-661.

Jewell, M., et al.

http://journals.lww.com/plasreconsurg/Abstract/2011/09000/Anaplastic_Large_T_Cell_Lymphoma_and_Breast.4.aspx

Anecdotal reports and one case-control study suggested an association, without evidence of causation, between breast implants and anaplastic lymphoma kinase–negative anaplastic large T-cell lymphoma (ALCL), a rare non-Hodgkin's lymphoma. This review summarizes the published evidence, including case reports and epidemiologic studies.

Extending the age range for breast screening in England

Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. Journal of medical screening, June 2011, vol. 18(2), p. 96-102.

Moser, K., et al.

http://jms.rsmjournals.com/content/18/2/96.short?rss=1

To assess the feasibility and acceptability of randomizing the phased introduction of the extension of the invited age range in the National Health Service (NHS) Breast Screening Programme in England from 50–70 to 47–73 years.

Screening outcomes in women over age 70 who self-refer in the NHSBSP in England

Screening outcomes in women over age 70 who self-refer in the NHSBSP in England. Journal of medical screening, June 2011, vol. 18(2), p. 291-295.

Bennett, RL, Moss, SM.

http://jms.rsmjournals.com/content/18/2/91.short?rss=1

The NHS breast screening programme (NHSBSP) in England currently invites women aged 50–70 every three years. Whilst screening is acknowledged as efficacious for women aged 50–69, several countries routinely invite women up to the age of 74. The NHSBSP in England is beginning to invite women up to the age of 73. Although the incidence of breast cancer increases with age, the possible benefits of screening older women must be balanced against shorter life expectancies and possible overdiagnosis. In England women can self-refer after reaching the invitation upper age limit.

Breast surface radiation dose during coronary CT angiography

Breast surface radiation dose during coronary CT angiography: Reduction by breast displacement and lead shielding. AJR, August 2011, vol. 197(2), p. 367-373.

Foley, SJ, et al.

http://www.ajronline.org/content/197/2/367.abstract?rss=1

The purpose of this study was to prospectively evaluate the effect of cranial breast displacement and lead shielding on in vivo breast surface radiation dose in women undergoing coronary CT angiography.

Microcalcifications around a collegen-based breast biopsy marker: complication of biopsy with a percutaneous marking system

Microcalcifications around a collegen-based breast biopsy marker: complication of biopsy with a percutaneous marking system. AJR, August 2011, vol. 197(2), p.W353 - W357

Trop, I., et al.

http://www.ajronline.org/content/197/2/W353.abstract?rss=1

The purpose of this article is to present the cases of four women who underwent percutaneous breast biopsy with deployment of a titanium metallic marker embedded in a bioresorbable collagen plug. Routine follow-up mammography after benign pathologic results were obtained revealed new fine microcalcifications at the biopsy sites, requiring repeat biopsy. Pathologic examination confirmed the presence of microcalcifications associated with an acidophilic foreign material.

Flat epithelial atypia of the breast: pathological-radiological correlation

Flat epithelial atypia of the breast: pathological-radiological correlation. AJR, Sept 2011, vol. 197(3), p. 740-746.

Solorzano, S., et al.

http://www.ajronline.org/content/197/3/740.abstract?rss=1

This study was undertaken to determine the prevalence of flat epithelial atypia at ultrasound-guided and stereotactically guided needle biopsies, to describe the mammographic and sonographic features of flat epithelial atypia, and to determine the significance of lesions diagnosed as flat epithelial atypia at imaging-guided needle biopsies.

Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions

Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions. AJR, Sept 2011, vol. 197(3), p. 732-739.

Moon, JH, et al.

http://www.ajronline.org/content/197/3/732.abstract?rss=1

The objective of this study was to prospectively evaluate the diagnostic accuracy of optical diffusion breast imaging in patients who underwent conventional ultrasound followed by surgery or biopsy.

Image guided preoperative hookwire localization of nonpalpable extramammory lesions

Image guided preoperative hookwire localization of nonpalpable extramammory lesions. AJR, Sept 2011, vol. 197(3), p. W525-W527

Kelan, KJ, et al.

http://www.ajronline.org/content/197/3/W525.abstract?rss=1

Imaging-guided hookwire localization of nonpalpable lesions in the breast is frequently performed preoperatively. Outside the breast, this procedure is useful for planning resection of lesions in anatomic regions without intrinsic landmarks. The purpose of this study was to review an experience with hookwire localization of nonpalpable extramammary lesions.